Drug Shortage Report for THALLOUS CHLORIDE TI-201 INJECTION
| Report ID | 171882 |
| Drug Identification Number | 02328925 |
| Brand name | THALLOUS CHLORIDE TI-201 INJECTION |
| Common or Proper name | thallous chloride Tl201 injection |
| Company Name | CURIUM CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | THALLIUM CHLORIDE |
| Strength(s) | 37MBq |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 2.8 to 9.9 mCi |
| ATC code | V09GX |
| ATC description | |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2022-10-07 |
| Actual start date | 2022-10-07 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2022-11-21 |
| Company comments | Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Please also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2022-11-21 | French | Compare |
| v7 | 2022-11-21 | English | Compare |
| v6 | 2022-10-24 | French | Compare |
| v5 | 2022-10-24 | English | Compare |
| v4 | 2022-10-24 | English | Compare |
| v3 | 2022-10-17 | French | Compare |
| v2 | 2022-10-17 | French | Compare |
| v1 | 2022-10-17 | English | Compare |
Showing 1 to 8 of 8